Find a researcher or lab Education & training programs MSK Innovation MSK Commercialization Ecosystem ...

If you have questions or concerns, contact your healthcare provider. A member of your care team will answer Monday through Friday from 9 a.m. to 5 p.m. Outside those hours, you can leave a message or ...

Find a researcher or lab Education & training programs MSK Innovation MSK Commercialization Ecosystem ...

To apply for a postdoc position, email your curriculum vitae and bibliography, along with a cover letter describing your background and career objectives, to the head of the research laboratory whose ...

The Evelyn H. Lauder Breast Center provides pioneering breast cancer services that go beyond the standard of care. We offer prevention, diagnosis, treatment, and support, all under one roof, in a ...

Acoustic neuroma — also called vestibular schwannoma — is a type of noncancerous tumor within the skull. It can cause problems with movement, balance, and hearing. Memorial Sloan Kettering experts can ...

We treat every type of cancer, including the most important one: yours. With cancer, where you get treated first matters. From diagnosis to treatment, our experts provide the care and support you need ...

How long you have your drain depends on your surgery and how much fluid is draining from your incision. As your incision heals, you’ll have less fluid. When no fluid drains from your Penrose drain for ...

Targeting the nectin-4 protein in bladder cancer On a search-and-destroy mission, enfortumab vedotin binds to a protein on cancer cells called nectin-4 and delivers a chemotherapy drug called ...

That cigarettes cause cancer is no secret. In addition to about 85% of lung cancers, cigarette smoking is responsible for a large fraction of bladder, head and neck, and esophageal cancers. Scientists ...

MSK gastrointestinal medical oncologist Dr. Wungki Park led the early phase clinical trial of daraxonrasib for people with metastatic pancreatic cancer that had stopped responding to chemotherapy.

Thoracic oncologist Kathryn Arbour, MD, led the Phase 1/2 clinical trial of daraxonrasib at MSK for metastatic lung cancer. The drug was approved by the FDA for pancreatic cancer in August 2026 and Dr ...